Related references
Note: Only part of the references are listed.Current status and limitations of immunotherapy for breast cancer
Yoshihisa Tokumaru et al.
SURGERY (2020)
Effects of MIR143 on rat sarcoma signaling networks in solid tumors: A brief overview
Yoshihisa Tokumaru et al.
CANCER SCIENCE (2020)
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma
Toshifumi Hoki et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo
Tomoaki Takai et al.
MOLECULAR THERAPY (2019)
Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients
Kerry-Ann McDonald et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase
Yoshihisa Tokumaru et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival
Maiko Okano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment
Yuki Yoshikawa et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis
Maiko Okano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma
Hideo Takahashi et al.
SURGERY (2019)
Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer
Sumana Narayanan et al.
SCIENTIFIC REPORTS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients
Judith C. Sporn et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer
Kazuhiro Araki et al.
BREAST CANCER (2018)
Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis
Masayuki Nagahashi et al.
CANCER RESEARCH (2018)
Impairment of K-Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR-143
Yukihiro Akao et al.
CANCER SCIENCE (2018)
ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer
Akimitsu Yamada et al.
MOLECULAR CANCER RESEARCH (2018)
High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy
Tomoaki Terakawa et al.
Oncotarget (2018)
Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process
Alireza Khodadadi-Jamayran et al.
Oncotarget (2018)
Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer
Tstutomu Kawaguchi et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
ASO Author Reflections: From Computer to Bedside: A New Translational Approach to Immunogenomics
Tsutomu Kawaguchi et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Eriko Katsuta et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Breast Cancer Immunotherapy: Facts and Hopes
Leisha A. Emens
CLINICAL CANCER RESEARCH (2018)
Adaptive immunity programmes in breast cancer
Frederick S. Varn et al.
IMMUNOLOGY (2017)
Murine breast cancer mastectomy model that predicts patient outcomes for drug development
Eriko Katsuta et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer
Eriko Katsuta et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer
Yumin Wu et al.
MOLECULAR MEDICINE REPORTS (2017)
Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival
Jessica Young et al.
ONCOTARGET (2017)
Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients
Tsutomu Kawaguchi et al.
SCIENTIFIC REPORTS (2017)
Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
Charles Johannessen et al.
PLOS ONE (2017)
Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA)
Sara Y. Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Angiopoietin pathway gene expression associated with poor breast cancer survival
Rajesh Ramanathan et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5
Limin Zhai et al.
MOLECULAR CARCINOGENESIS (2016)
The immune system and hormone-receptor positive breast cancer: Is it really a dead end?
Maria Vittoria Dieci et al.
CANCER TREATMENT REVIEWS (2016)
Modified breast cancer model for preclinical immunotherapy studies
Eriko Katsuta et al.
JOURNAL OF SURGICAL RESEARCH (2016)
被撤回的出版物: MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma (Retracted article. See vol. 21, 2022)
Zhenyue He et al.
MOLECULAR CANCER (2016)
Innate Immune Recognition of Cancer
Seng-Ryong Woo et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer
Kohei Taniguchi et al.
CANCER LETTERS (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells
James Neil Fisher et al.
ONCOTARGET (2015)
Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms
Kohei Taniguchi et al.
SCIENTIFIC REPORTS (2015)
Animal models for exploring the pharmacokinetics of breast cancer therapies
Omar M. Rashid et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
An improved syngeneic orthotopic murine model of human breast cancer progression
Omar M. Rashid et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer
Xin Yan et al.
MOLECULAR CANCER (2014)
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
Annette R. Kodahl et al.
MOLECULAR ONCOLOGY (2014)
The regulation of toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells
Haiyan Guo et al.
MOLECULAR CANCER (2013)
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Sphingosine-1-Phosphate Produced by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis
Masayuki Nagahashi et al.
CANCER RESEARCH (2012)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Role of anti-oncomirs miR-143 and-145 in human colorectal tumors
Y. Akao et al.
CANCER GENE THERAPY (2010)
Inflammation and breast cancer - Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G. DeNardo et al.
BREAST CANCER RESEARCH (2007)
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data
AR Abbas et al.
GENES AND IMMUNITY (2005)
Share Paper
